Bagatell, R., London, W. B., Wagner, L. M., Voss, S. D., Stewart, C. F., Maris, J. M., . . . Cohn, S. L. (2011). Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study. American Society of Clinical Oncology.
Chicago Style CitationBagatell, Rochelle, Wendy B. London, Lars M. Wagner, Stephan D. Voss, Clinton F. Stewart, John M. Maris, Cynthia Kretschmar, and Susan L. Cohn. Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study. American Society of Clinical Oncology, 2011.
MLA CitationBagatell, Rochelle, et al. Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study. American Society of Clinical Oncology, 2011.